Cargando…
CCR3 plays a role in murine age-related cognitive changes and T-cell infiltration into the brain
Targeting immune-mediated, age-related, biology has the potential to be a transformative therapeutic strategy. However, the redundant nature of the multiple cytokines that change with aging requires identification of a master downstream regulator to successfully exert therapeutic efficacy. Here, we...
Autores principales: | Rege, Sanket V., Teichert, Arnaud, Masumi, Juliet, Dhande, Onkar S., Harish, Reema, Higgins, Brett W., Lopez, Yesenia, Akrapongpisak, Lily, Hackbart, Hannah, Caryotakis, Sofia, Leone, Dino P., Szoke, Balazs, Hannestad, Jonas, Nikolich, Karoly, Braithwaite, Steven P., Minami, S. Sakura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024715/ https://www.ncbi.nlm.nih.gov/pubmed/36934154 http://dx.doi.org/10.1038/s42003-023-04665-w |
Ejemplares similares
-
Molecular and histological correlates of cognitive decline across age in male C57BL/6J mice
por: Britton, Rachel, et al.
Publicado: (2022) -
Leukotriene A4 hydrolase inhibition improves age-related cognitive decline via modulation of synaptic function
por: Adams, Julia M., et al.
Publicado: (2023) -
Safety and tolerability of GRF6019 in mild‐to‐moderate Alzheimer's disease dementia
por: Hannestad, Jonas, et al.
Publicado: (2020) -
A Pharmacological Screening Approach for Discovery of Neuroprotective Compounds in Ischemic Stroke
por: Beraki, Simret, et al.
Publicado: (2013) -
Deep Longitudinal Proteomics Profiling Reveals Biological Pathways Responding to GRF6019 in Two AD Clinical Trials
por: Lehallier, Benoit, et al.
Publicado: (2021)